Champions Oncology (CSBR) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -6.41% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 25.73% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -7.33% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -26.16% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -34.42% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 35.41% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 45.04% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -12.18% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 45.04% |
| Apr 30, 2026 | 36.14% |
| Jan 31, 2026 | 51.46% |
| Oct 31, 2025 | 156.18% |
| Jul 31, 2025 | -13.47% |
| Apr 30, 2025 | -74.73% |
| Jan 31, 2025 | 78.75% |
| Oct 31, 2024 | 38.00% |
| Jul 31, 2024 | 112.78% |
| Apr 30, 2024 | 45.49% |
| Jan 31, 2024 | -66.77% |
| Oct 31, 2023 | -1,175.07% |
| Jul 31, 2023 | -230.84% |
| Apr 30, 2023 | -5.76% |
| Jan 31, 2023 | -99.94% |
| Oct 31, 2022 | -27.08% |
| Jul 31, 2022 | 20.75% |
| Apr 30, 2022 | -10.78% |
| Jan 31, 2022 | 60.48% |
| Oct 31, 2021 | 1.23% |